Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA302007
Max Phase: Preclinical
Molecular Formula: C17H15ClN2O
Molecular Weight: 298.77
Molecule Type: Small molecule
Associated Items:
ID: ALA302007
Max Phase: Preclinical
Molecular Formula: C17H15ClN2O
Molecular Weight: 298.77
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: OC1(Cc2ccc(Cl)cc2)c2ccccc2C2=NCCN21
Standard InChI: InChI=1S/C17H15ClN2O/c18-13-7-5-12(6-8-13)11-17(21)15-4-2-1-3-14(15)16-19-9-10-20(16)17/h1-8,21H,9-11H2
Standard InChI Key: FNLMEDGQBVFDCQ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 298.77 | Molecular Weight (Monoisotopic): 298.0873 | AlogP: 2.80 | #Rotatable Bonds: 2 |
Polar Surface Area: 35.83 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.20 | CX Basic pKa: 4.49 | CX LogP: 3.50 | CX LogD: 3.49 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.93 | Np Likeness Score: -0.12 |
1. del Olmo E, Armas MG, López-Pérez JL, Muñoz V, Deharo E, San Feliciano A.. (2001) Leishmanicidal activity of some stilbenoids and related heterocyclic compounds., 11 (16): [PMID:11514152] [10.1016/s0960-894x(01)00387-0] |
2. del Olmo E, Armas MG, López-Pérez JL, Ruiz G, Vargas F, Giménez A, Deharo E, San Feliciano A.. (2001) Anti-Trypanosoma activity of some natural stilbenoids and synthetic related heterocyclic compounds., 11 (20): [PMID:11591517] [10.1016/s0960-894x(01)00562-5] |
3. del Olmo E, Armas MG, Ybarra M, López JL, Oporto P, Giménez A, Deharo E, San Feliciano A.. (2003) The imidazo[2,1-a]isoindole system. A new skeletal basis for antiplasmodial compounds., 13 (16): [PMID:12873511] [10.1016/s0960-894x(03)00509-2] |
4. del Olmo E, Barboza B, Ybarra MI, López-Pérez JL, Carrón R, Sevilla MA, Boselli C, San Feliciano A.. (2006) Vasorelaxant activity of phthalazinones and related compounds., 16 (10): [PMID:16513345] [10.1016/j.bmcl.2006.02.003] |
5. Bedoya LM, del Olmo E, Sancho R, Barboza B, Beltrán M, García-Cadenas AE, Sánchez-Palomino S, López-Pérez JL, Muñoz E, San Feliciano A, Alcamí J.. (2006) Anti-HIV activity of stilbene-related heterocyclic compounds., 16 (15): [PMID:16713260] [10.1016/j.bmcl.2006.04.087] |
6. Zamilpa A, Herrera-Ruiz M, Del Olmo E, López-Pérez JL, Tortoriello J, San Feliciano A.. (2007) [1,3]Diazaheterofused isoindolol derivatives displaying anxiolytic-like effects on mice., 17 (14): [PMID:17507222] [10.1016/j.bmcl.2007.04.080] |
7. del Olmo E, Barboza B, Chiaradia LD, Moreno A, Carrero-Lérida J, González-Pacanowska D, Muñoz V, López-Pérez JL, Giménez A, Benito A, Martínez AR, Ruiz-Pérez LM, San Feliciano A.. (2011) Antimalarial activity of imidazo[2,1-a]isoindol-5-ol derivatives and related compounds., 46 (11): [PMID:21940072] [10.1016/j.ejmech.2011.08.043] |
8. Arsène S, Gómez-Pérez V, Escarcena R, Abengózar MÁ, García-Hernández R, Nácher-Vázquez M, San Feliciano A, Gamarro F, Rivas L, Olmo ED.. (2019) Imidazo[2,1-a]isoindole scaffold as an uncharted structure active on Leishmania donovani., 182 [PMID:31419778] [10.1016/j.ejmech.2019.111568] |
Source(1):